The high expression of indoleamine 2,3-dioxygenase 1 (IDO1) in tumors facilitates the conversion of tryptophan to kynurenine, thereby promoting the establishment of a tumor immune-suppressive microenvironment. Here, IDO1 is linked to neoplasm.